In 2006, there were several reimbursement developments that affect the medical device industry. CMS issued a guidance document on coverage with evidence development (CED). It also approved two initiatives to explore the benefits of gainsharing between hospitals and physicians. In addition, the centers issued a proposed rule containing new coverage and payment policies for certain diagnostic imaging services. And it proposed a competitive acquisition program for durable medical equipment (DME).
By learning about these events, medical device makers have an opportunity to prepare for the subtle changes that could lead to big problems (or solutions) down the road. This article discusses each development and offers analysis on how industry is responding.
Read the entire article.
By learning about these events, medical device makers have an opportunity to prepare for the subtle changes that could lead to big problems (or solutions) down the road. This article discusses each development and offers analysis on how industry is responding.
Read the entire article.
Related Insights
21 May 2025
Tariff & International Trade Resource
What Every Multinational Company Should Know About … Customs Enforcement and False Claims Act Risks (Part III)
We complete the series on “Customs Enforcement and False Claims Act Risks” with Part III, which focuses on preparing for the most common FCA risks arising from improper management of import operations.
02 June 2025
Events
Biotech Panel Discussion & Happy Hour
Join Foley & Lardner LLP along with Biotech XYZ for an engaging evening event featuring a dynamic panel discussion and a lively happy hour.
03 June 2025
Events
Biotech Breakfast + Office Hours
Join Foley & Lardner LLP along with Biotech XYZ for Phase Capitals’ flagship networking biotech breakfast and office hours with Q&A sessions.